These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19805123)

  • 1. NF-kappaB activity is constitutively elevated in c-Abl null fibroblasts.
    Liberatore RA; Goff SP; Nunes I
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17823-8. PubMed ID: 19805123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitor trichostatin A sustains sodium pervanadate-induced NF-kappaB activation by delaying IkappaBalpha mRNA resynthesis: comparison with tumor necrosis factor alpha.
    Horion J; Gloire G; El Mjiyad N; Quivy V; Vermeulen L; Vanden Berghe W; Haegeman G; Van Lint C; Piette J; Habraken Y
    J Biol Chem; 2007 May; 282(21):15383-93. PubMed ID: 17409387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of NF-kappaB-dependent cell survival, a novel mechanism for the proapoptotic function of c-Abl.
    Kawai H; Nie L; Yuan ZM
    Mol Cell Biol; 2002 Sep; 22(17):6079-88. PubMed ID: 12167702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Bcr-Abl-mediated NF-kappaB/Rel activation.
    Kirchner D; Duyster J; Ottmann O; Schmid RM; Bergmann L; Munzert G
    Exp Hematol; 2003 Jun; 31(6):504-11. PubMed ID: 12829026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
    Hu J; Colburn NH
    Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor.
    Sun J; Kong J; Duan Y; Szeto FL; Liao A; Madara JL; Li YC
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E315-22. PubMed ID: 16507601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IKK-2/Ikappa Balpha /NF-kappa B pathway plays a key role in the regulation of CCR3 and eotaxin-1 in fibroblasts. A critical link to dermatitis in Ikappa Balpha -deficient mice.
    Huber MA; Denk A; Peter RU; Weber L; Kraut N; Wirth T
    J Biol Chem; 2002 Jan; 277(2):1268-75. PubMed ID: 11694538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis.
    Takada Y; Singh S; Aggarwal BB
    J Biol Chem; 2004 Apr; 279(15):15096-104. PubMed ID: 14711835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mastermind-like 1 (MAML1) co-activator regulates constitutive NF-kappaB signaling and cell survival.
    Jin B; Shen H; Lin S; Li JL; Chen Z; Griffin JD; Wu L
    J Biol Chem; 2010 May; 285(19):14356-65. PubMed ID: 20231278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.
    Ashburner BP; Westerheide SD; Baldwin AS
    Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival.
    Lu Y; Jamieson L; Brasier AR; Fields AP
    Oncogene; 2001 Aug; 20(35):4777-92. PubMed ID: 11521190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of nuclear NF-kappaB action regulated by reversible acetylation.
    Chen Lf ; Fischle W; Verdin E; Greene WC
    Science; 2001 Aug; 293(5535):1653-7. PubMed ID: 11533489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells.
    Dikov MM; Oyama T; Cheng P; Takahashi T; Takahashi K; Sepetavec T; Edwards B; Adachi Y; Nadaf S; Daniel T; Gabrilovich DI; Carbone DP
    Cancer Res; 2001 Mar; 61(5):2015-21. PubMed ID: 11280761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
    Shukla S; Gupta S
    Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.
    Matsushima A; Kaisho T; Rennert PD; Nakano H; Kurosawa K; Uchida D; Takeda K; Akira S; Matsumoto M
    J Exp Med; 2001 Mar; 193(5):631-6. PubMed ID: 11238593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of NF-kappaB by Toxoplasma gondii correlates with increased expression of antiapoptotic genes and localization of phosphorylated IkappaB to the parasitophorous vacuole membrane.
    Molestina RE; Payne TM; Coppens I; Sinai AP
    J Cell Sci; 2003 Nov; 116(Pt 21):4359-71. PubMed ID: 12966164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
    Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
    J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Differentiation Regulator p100 Tunes NF-κB Responses to TNF.
    Chatterjee B; Roy P; Sarkar UA; Zhao M; Ratra Y; Singh A; Chawla M; De S; Gomes J; Sen R; Basak S
    Front Immunol; 2019; 10():997. PubMed ID: 31134075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha.
    Adam E; Quivy V; Bex F; Chariot A; Collette Y; Vanhulle C; Schoonbroodt S; Goffin V; Nguyên TL; Gloire G; Carrard G; Friguet B; De Launoit Y; Burny A; Bours V; Piette J; Van Lint C
    Mol Cell Biol; 2003 Sep; 23(17):6200-9. PubMed ID: 12917341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation.
    Dai Y; Rahmani M; Dent P; Grant S
    Mol Cell Biol; 2005 Jul; 25(13):5429-44. PubMed ID: 15964800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.